Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Larissa Stassek, MPH

Program Manager
Evidera

Disclosure(s): ViiV Healthcare: Advisor/Consultant, Travel support

Poster(s):

(P-1424) Patient Experiences at Month 6 after Initiation of Cabotegravir Long-Acting (CAB LA) for PrEP in the First Male Gender Concordant Implementation Science Trial (PILLAR) in the US

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT